​

Chemomab Therapeutics Ownership | Who Owns Chemomab Therapeutics?

OverviewForecastChart

Chemomab Therapeutics Ownership Summary

Chemomab Therapeutics is owned by 0.93% institutional investors, 16.73% insiders, and 82.35% retail investors. Two sigma securities is the largest institutional shareholder, holding 0% of CMMB shares.

CMMB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockChemomab Therapeutics0.93%16.73%82.35%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Two sigma securities---
Yelin lapidot management---
Jane street group---
Gamma investing---
Rhumbline advisers---
Boothbay fund management---
Virtu financial---
Kestra private wealth services---
Wetzel investment advisors---
Ikarian capital---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma securities---
Yelin lapidot management---
Jane street group---
Gamma investing---
Rhumbline advisers---
Boothbay fund management---
Virtu financial---
Kestra private wealth services---
Wetzel investment advisors---
Ikarian capital---

Top Buyers

HolderShares% AssetsChange
Sbi securities---111.00
Ubs group---397.00
Moser wealth advisors---500.00
Jpmorgan chase---1.18K
Wetzel investment advisors---11.00K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---940.99K
Sphera funds management---738.05K
Yelin lapidot management---578.29K
Ikarian capital---213.05K
Rhumbline advisers---39.88K

Sold Out

HolderChange
Sbi securities-111.00
Ubs group-397.00
Moser wealth advisors-500.00
Jpmorgan chase-1.18K
Wetzel investment advisors-11.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202514-17.65%4,230,78813.37%-70.20%7-22.22%3-
Mar 31, 2025176.25%3,731,679-10.31%169.98%950.00%3-50.00%
Dec 31, 2024166.67%4,160,723-8.55%176.12%6-40.00%6500.00%
Sep 30, 202415-4,549,76770.23%1148.65%10100.00%1-66.67%
Jun 30, 2024157.14%2,672,7560.42%-106.48%525.00%350.00%

Recent Insider Transactions

DateNameRoleActivityValue
Jan 03, 2023OrbiMed Israel GP Ltd.-Sell$318.06K
Jan 03, 2023OrbiMed Israel GP Ltd.-Sell$889.70K
Jan 03, 2023Mor George Adi Chief Scientific OfficerSell$38.71K
Jan 03, 2023Mor George Adi Chief Scientific OfficerSell$30.66K
Nov 16, 2022Cohen Neil Harris-Sell$4.82K

Insider Transactions Trends

DateBuySell
2023 Q2--
2023 Q1-4
2022 Q4-3
2022 Q22-
2022 Q16-

CMMB Ownership FAQ

Who Owns Chemomab Therapeutics?

Chemomab Therapeutics shareholders are primarily institutional investors at 0.93%, followed by 16.73% insiders and 82.34% retail investors. The average institutional ownership in Chemomab Therapeutics's industry, Biotech Stocks , is 45.22%, which Chemomab Therapeutics falls below.

Who owns the most shares of Chemomab Therapeutics?

Chemomab Therapeutics’s largest shareholders are Two sigma securities (0 shares, 0%), Yelin lapidot management (0 shares, 0%), and Jane street group (0 shares, 0%). Together, they hold 0% of Chemomab Therapeutics’s total shares outstanding.

Does Blackrock own Chemomab Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Chemomab Therapeutics.

Who is Chemomab Therapeutics’s biggest shareholder by percentage of total assets invested?

Two sigma securities is Chemomab Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Chemomab Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools